Master Regulators: Therapeutic Vulnerabilities Explained

Here’s a breakdown ​of the details ⁤provided, formatted for clarity:

Research Articles:

* Patrick J. Cunniff et al. (2025). KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators ​RUVBL1‍ and RUVBL2.Nature Communications. DOI: 10.1038/s41467-025-66007-0
* Aktan Alpsoy et‍ al. (2025).Structural​ basis of DNA-dependent coactivator recruitment by the tuft cell master ⁤regulator POU2F3.​ Cell Reports. DOI: 10.1016/j.celrep.2025.116572

Source:

* Provided ⁣by: Cold Spring Harbor Laboratory (https://medicalxpress.com/partners/cold-spring-harbor-laboratory/, http://www.cshl.edu/index.html)

News ⁣Article Citation:

* Title: Shapeshifting tumors unmasked: New insights into master regulators reveal therapeutic vulnerabilities
* Date: November 25, 2025